Novel Treatment for Premature Ejaculation Shows Promising Results

SAN FRANCISCO—Pivotal clinical trials of a novel treatment for premature ejaculation (PE) have yielded promising results, a researcher announced here at a press conference during the American Urological Association annual meeting.

Time to BCR Affects Survival Likelihood in High-Risk PCa Patients

SAN FRANCISCO—Nearly one in five men who undergo radical prostatectomy (RP) for high-risk prostate cancer experience biochemical recurrence (BCR) within two years of surgery, according to the findings of a European study.

Undetectable PSA 10 Years Post-Op Predicts Low Risk of PSA Relapse

SAN FRANCISCO—Prostate cancer patients who have undetectable PSA levels 10 years after undergoing a radical prostatectomy (RP) have a low likelihood of experiencing biochemical recurrence (BCR) of their cancer or of dying from the malignancy, according to researchers.

Factors Associated with Male Urinary Incontinence Identified

SAN FRANCISCO—Major depression, hypertension, and prostatic enlargement are independently associated with moderate to severe urinary incontinence (UI) in men aged 40 years and older, according to researchers.

Dutasteride May Ease Prostatitis-Related Symptoms

SAN FRANCISCO—Dutasteride treatment may decrease prostatitis-related symptoms, data suggest.

Urinary Health Worse in Prostate Cancer Patients

SAN FRANCISCO—Prostate cancer is associated with significantly increased urinary bother in community-dwelling older men with lower urinary tract symptoms (LUTS), data suggest.

Delaying Radical Surgery for Low-Risk Prostate Cancer Could Worsen Outcomes

SAN FRANCISCO—Men with low-risk prostate cancer who delay undergoing radical prostatectomy (RP) for six months or more after diagnosis may have worse outcomes post-operatively than those who undergo RP within six months, according to researchers.

Improved Survival with RP vs. Radiation

Improved Survival with RP vs. Radiation

SAN FRANCISCO—Radical prostatectomy (RP) is associated with significantly better intermediate-term survival than radiation treatment among men with clinically localized prostate cancer, data suggest.

Overactive Bladder Linked to Inflammation

SAN FRANCISCO—Increasing levels of C-reactive protein (CRP) are associated with increasing odds of overactive bladder (OAB), according to a population-based study of men and women.

Radiotherapy for Prostate Cancer May Raise Hip Fracture Risk

SAN FRANCISCO—Men who undergo three-dimensional external beam radiotherapy (3D-EBRT) for prostate cancer may be at elevated risk for hip fractures, according to researchers.

Nephrometry May Improve Renal Cancer Care

Researchers have developed a standardized scoring system for quantifying renal tumor size, location, and depth.

Autologous Cells May Ease Stress Urinary Incontinence

Injecting autologous muscle-derived cells (AMDCs) into the bladder may significantly improve symptoms and quality of life (QOL) in patients with stress urinary incontinence (SUI), according to Canadian researchers.

Pomegranate Juice May Help Prostate Cancer Patients

Pomegranate Juice May Help Prostate Cancer Patients

Pomegranate juice may help slow progression of prostate cancer in men who experience rising PSA levels following radical prostatectomy or radiotherapy, data suggest.

Dutasteride Found to Lower PCa Risk

CHICAGO—Dutasteride lowers the risk of prostate cancer by 23% in men with an increased risk of the malignancy, new findings show.

Kidney Stones, Heart Disease Linked in Older Women

Heart disease is significantly more prevalent in older white women with a history of kidney stones than in those who have never had a kidney stone, new findings suggest.

PSA Density Predicts Worse Prostate Cancer Pathology

PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found.

Formula Might Overdiagnose Renal Dysfunction

Use of the Modification of Diet in Renal Disease (MDRD) study formula may overestimate the number patients with renal dysfunction, according to researchers at the Roswell Park Cancer Institute in Buffalo.

Prostate Cancer Vaccine Improves Survival

CHICAGO—Sipuleucel-T (Provenge), an experimental immunotherapeutic vaccine, prolonged survival in men with metastatic, androgen-independent prostate cancer, according to study findings presented here at the American Urological Association annual meeting.

New AUA Recommendation: Start Offering PSA Testing at 40

CHICAGO—The American Urological Association (AUA) recommends that PSA testing should be offered to well-informed men aged 40 years and older who have a life expectancy of at least 10 years.

Sign Up for Free e-newsletters